Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for NFIA
Z-value: 2.18
Motif logo
Transcription factors associated with NFIA
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
NFIA
|
ENSG00000162599.11 | nuclear factor I A |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| NFIA | hg19_v2_chr1_+_61330931_61331017 | 0.92 | 1.4e-08 | Click! |
Activity profile of NFIA motif
Sorted Z-values of NFIA motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_42947121 | 15.84 |
ENST00000601181.1
|
CXCL17
|
chemokine (C-X-C motif) ligand 17 |
| chr18_+_61144160 | 13.20 |
ENST00000489441.1
ENST00000424602.1 |
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
| chr12_-_52911718 | 12.48 |
ENST00000548409.1
|
KRT5
|
keratin 5 |
| chr18_+_61143994 | 12.42 |
ENST00000382771.4
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
| chr7_-_41742697 | 12.00 |
ENST00000242208.4
|
INHBA
|
inhibin, beta A |
| chr17_-_39661849 | 11.45 |
ENST00000246635.3
ENST00000336861.3 ENST00000587544.1 ENST00000587435.1 |
KRT13
|
keratin 13 |
| chr12_-_52914155 | 11.36 |
ENST00000549420.1
ENST00000551275.1 ENST00000546577.1 |
KRT5
|
keratin 5 |
| chr7_+_129932974 | 11.00 |
ENST00000445470.2
ENST00000222482.4 ENST00000492072.1 ENST00000473956.1 ENST00000493259.1 ENST00000486598.1 |
CPA4
|
carboxypeptidase A4 |
| chr19_+_42254885 | 9.98 |
ENST00000595740.1
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) |
| chr6_+_106959718 | 9.18 |
ENST00000369066.3
|
AIM1
|
absent in melanoma 1 |
| chr8_+_124194752 | 8.95 |
ENST00000318462.6
|
FAM83A
|
family with sequence similarity 83, member A |
| chr21_-_28215332 | 8.93 |
ENST00000517777.1
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
| chr13_+_78109884 | 8.78 |
ENST00000377246.3
ENST00000349847.3 |
SCEL
|
sciellin |
| chr12_-_28125638 | 8.74 |
ENST00000545234.1
|
PTHLH
|
parathyroid hormone-like hormone |
| chr13_+_78109804 | 8.46 |
ENST00000535157.1
|
SCEL
|
sciellin |
| chr11_+_34654011 | 8.44 |
ENST00000531794.1
|
EHF
|
ets homologous factor |
| chr8_+_124194875 | 8.34 |
ENST00000522648.1
ENST00000276699.6 |
FAM83A
|
family with sequence similarity 83, member A |
| chr17_-_39661947 | 7.44 |
ENST00000590425.1
|
KRT13
|
keratin 13 |
| chr17_-_39093672 | 7.29 |
ENST00000209718.3
ENST00000436344.3 ENST00000485751.1 |
KRT23
|
keratin 23 (histone deacetylase inducible) |
| chr2_+_54684327 | 6.85 |
ENST00000389980.3
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1 |
| chr18_+_61254221 | 6.59 |
ENST00000431153.1
|
SERPINB13
|
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
| chr19_-_43969796 | 6.35 |
ENST00000244333.3
|
LYPD3
|
LY6/PLAUR domain containing 3 |
| chr11_-_118134997 | 6.21 |
ENST00000278937.2
|
MPZL2
|
myelin protein zero-like 2 |
| chr18_+_61254570 | 6.14 |
ENST00000344731.5
|
SERPINB13
|
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
| chr2_-_113542063 | 5.96 |
ENST00000263339.3
|
IL1A
|
interleukin 1, alpha |
| chr10_+_24528108 | 5.80 |
ENST00000438429.1
|
KIAA1217
|
KIAA1217 |
| chr1_+_209878182 | 5.74 |
ENST00000367027.3
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
| chr2_-_31637560 | 5.60 |
ENST00000379416.3
|
XDH
|
xanthine dehydrogenase |
| chr18_+_61254534 | 5.58 |
ENST00000269489.5
|
SERPINB13
|
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
| chr6_-_56492816 | 5.53 |
ENST00000522360.1
|
DST
|
dystonin |
| chr6_-_32784687 | 5.29 |
ENST00000447394.1
ENST00000438763.2 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
| chr17_-_39769005 | 5.26 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
| chr1_+_68150744 | 5.25 |
ENST00000370986.4
ENST00000370985.3 |
GADD45A
|
growth arrest and DNA-damage-inducible, alpha |
| chr4_-_157892055 | 4.93 |
ENST00000422544.2
|
PDGFC
|
platelet derived growth factor C |
| chr3_+_121613265 | 4.93 |
ENST00000295605.2
|
SLC15A2
|
solute carrier family 15 (oligopeptide transporter), member 2 |
| chr1_-_39407467 | 4.89 |
ENST00000540558.1
|
RHBDL2
|
rhomboid, veinlet-like 2 (Drosophila) |
| chr9_+_130911770 | 4.68 |
ENST00000372998.1
|
LCN2
|
lipocalin 2 |
| chr3_-_176914191 | 4.64 |
ENST00000437738.1
ENST00000424913.1 ENST00000443315.1 |
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1 |
| chr16_-_79634595 | 4.50 |
ENST00000326043.4
ENST00000393350.1 |
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
| chr4_-_87028478 | 4.39 |
ENST00000515400.1
ENST00000395157.3 |
MAPK10
|
mitogen-activated protein kinase 10 |
| chr1_-_209792111 | 4.37 |
ENST00000455193.1
|
LAMB3
|
laminin, beta 3 |
| chr11_+_34643600 | 4.21 |
ENST00000530286.1
ENST00000533754.1 |
EHF
|
ets homologous factor |
| chr1_-_39407450 | 4.20 |
ENST00000372990.1
|
RHBDL2
|
rhomboid, veinlet-like 2 (Drosophila) |
| chr14_-_24732403 | 4.20 |
ENST00000206765.6
|
TGM1
|
transglutaminase 1 |
| chr12_-_53207842 | 4.16 |
ENST00000458244.2
|
KRT4
|
keratin 4 |
| chr4_+_30721968 | 4.15 |
ENST00000361762.2
|
PCDH7
|
protocadherin 7 |
| chr3_-_105588231 | 4.12 |
ENST00000545639.1
ENST00000394027.3 ENST00000438603.1 ENST00000447441.1 ENST00000443752.1 |
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
| chr9_+_130911723 | 4.08 |
ENST00000277480.2
ENST00000373013.2 ENST00000540948.1 |
LCN2
|
lipocalin 2 |
| chr10_-_126138622 | 4.06 |
ENST00000451024.3
|
NKX1-2
|
NK1 homeobox 2 |
| chr4_-_157892167 | 4.03 |
ENST00000541126.1
|
PDGFC
|
platelet derived growth factor C |
| chr16_+_82090028 | 4.03 |
ENST00000568090.1
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2 |
| chr18_+_20494078 | 4.00 |
ENST00000579124.1
ENST00000577588.1 ENST00000582354.1 ENST00000581819.1 |
RBBP8
|
retinoblastoma binding protein 8 |
| chr5_-_141249154 | 3.95 |
ENST00000357517.5
ENST00000536585.1 |
PCDH1
|
protocadherin 1 |
| chr14_-_24732368 | 3.81 |
ENST00000544573.1
|
TGM1
|
transglutaminase 1 |
| chr1_+_95975672 | 3.81 |
ENST00000440116.2
ENST00000456933.1 |
RP11-286B14.1
|
RP11-286B14.1 |
| chr12_+_56324756 | 3.71 |
ENST00000331886.5
ENST00000555090.1 |
DGKA
|
diacylglycerol kinase, alpha 80kDa |
| chr2_+_17721230 | 3.70 |
ENST00000457525.1
|
VSNL1
|
visinin-like 1 |
| chr2_-_163099885 | 3.67 |
ENST00000443424.1
|
FAP
|
fibroblast activation protein, alpha |
| chr6_-_30043539 | 3.60 |
ENST00000376751.3
ENST00000244360.6 |
RNF39
|
ring finger protein 39 |
| chr6_+_108977520 | 3.59 |
ENST00000540898.1
|
FOXO3
|
forkhead box O3 |
| chr14_+_71165292 | 3.54 |
ENST00000553682.1
|
RP6-65G23.1
|
RP6-65G23.1 |
| chr2_-_163100045 | 3.47 |
ENST00000188790.4
|
FAP
|
fibroblast activation protein, alpha |
| chr5_+_3596168 | 3.41 |
ENST00000302006.3
|
IRX1
|
iroquois homeobox 1 |
| chr1_+_24646002 | 3.34 |
ENST00000356046.2
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
| chr7_-_17598506 | 3.30 |
ENST00000451792.1
|
AC017060.1
|
AC017060.1 |
| chr17_-_38657849 | 3.27 |
ENST00000254051.6
|
TNS4
|
tensin 4 |
| chr11_-_61101247 | 3.27 |
ENST00000543627.1
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa |
| chr14_-_36988882 | 3.25 |
ENST00000498187.2
|
NKX2-1
|
NK2 homeobox 1 |
| chr1_+_44399347 | 3.21 |
ENST00000477048.1
ENST00000471394.2 |
ARTN
|
artemin |
| chr14_-_75079026 | 3.21 |
ENST00000261978.4
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
| chr14_-_69350920 | 3.20 |
ENST00000553290.1
|
ACTN1
|
actinin, alpha 1 |
| chr3_-_74570291 | 3.20 |
ENST00000263665.6
|
CNTN3
|
contactin 3 (plasmacytoma associated) |
| chr11_-_58343319 | 3.15 |
ENST00000395074.2
|
LPXN
|
leupaxin |
| chr11_-_13461790 | 3.13 |
ENST00000530907.1
|
BTBD10
|
BTB (POZ) domain containing 10 |
| chr12_+_8995832 | 3.10 |
ENST00000541459.1
|
A2ML1
|
alpha-2-macroglobulin-like 1 |
| chr7_-_24957699 | 3.07 |
ENST00000441059.1
ENST00000415162.1 |
OSBPL3
|
oxysterol binding protein-like 3 |
| chr13_-_40177261 | 2.98 |
ENST00000379589.3
|
LHFP
|
lipoma HMGIC fusion partner |
| chr4_+_146402925 | 2.97 |
ENST00000302085.4
|
SMAD1
|
SMAD family member 1 |
| chr5_-_74807418 | 2.95 |
ENST00000405807.4
ENST00000261415.7 |
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein |
| chr16_-_66785497 | 2.93 |
ENST00000440564.2
ENST00000379482.2 ENST00000443351.2 ENST00000566150.1 |
DYNC1LI2
|
dynein, cytoplasmic 1, light intermediate chain 2 |
| chr8_-_42358742 | 2.90 |
ENST00000517366.1
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
| chr16_-_65106110 | 2.86 |
ENST00000562882.1
ENST00000567934.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
| chr11_-_35547151 | 2.80 |
ENST00000378878.3
ENST00000529303.1 ENST00000278360.3 |
PAMR1
|
peptidase domain containing associated with muscle regeneration 1 |
| chr1_+_24645915 | 2.77 |
ENST00000350501.5
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
| chr7_-_151330218 | 2.77 |
ENST00000476632.1
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
| chr10_+_135340859 | 2.75 |
ENST00000252945.3
ENST00000421586.1 ENST00000418356.1 |
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1 |
| chr2_-_214013353 | 2.74 |
ENST00000451136.2
ENST00000421754.2 ENST00000374327.4 ENST00000413091.3 |
IKZF2
|
IKAROS family zinc finger 2 (Helios) |
| chr17_-_74533963 | 2.73 |
ENST00000293230.5
|
CYGB
|
cytoglobin |
| chr12_+_56324933 | 2.73 |
ENST00000549629.1
ENST00000555218.1 |
DGKA
|
diacylglycerol kinase, alpha 80kDa |
| chr1_+_44399466 | 2.66 |
ENST00000498139.2
ENST00000491846.1 |
ARTN
|
artemin |
| chr1_+_24646263 | 2.66 |
ENST00000524724.1
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
| chr9_-_99064386 | 2.61 |
ENST00000375262.2
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3 |
| chr6_-_56716686 | 2.57 |
ENST00000520645.1
|
DST
|
dystonin |
| chr17_+_7461580 | 2.56 |
ENST00000483039.1
ENST00000396542.1 |
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
| chr2_+_102953608 | 2.55 |
ENST00000311734.2
ENST00000409584.1 |
IL1RL1
|
interleukin 1 receptor-like 1 |
| chr9_-_99064429 | 2.55 |
ENST00000375263.3
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3 |
| chr18_-_47792851 | 2.54 |
ENST00000398545.4
|
CCDC11
|
coiled-coil domain containing 11 |
| chr12_+_110718428 | 2.54 |
ENST00000552636.1
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
| chr22_-_38699003 | 2.54 |
ENST00000451964.1
|
CSNK1E
|
casein kinase 1, epsilon |
| chr17_+_7462031 | 2.53 |
ENST00000380535.4
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
| chr5_+_112073544 | 2.52 |
ENST00000257430.4
ENST00000508376.2 |
APC
|
adenomatous polyposis coli |
| chr14_-_75078725 | 2.50 |
ENST00000556690.1
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
| chr3_-_93747425 | 2.49 |
ENST00000315099.2
|
STX19
|
syntaxin 19 |
| chr3_+_184032919 | 2.46 |
ENST00000427845.1
ENST00000342981.4 ENST00000319274.6 |
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1 |
| chr1_+_110546700 | 2.45 |
ENST00000359172.3
ENST00000393614.4 |
AHCYL1
|
adenosylhomocysteinase-like 1 |
| chr1_+_10093188 | 2.41 |
ENST00000377153.1
|
UBE4B
|
ubiquitination factor E4B |
| chr11_-_128392085 | 2.39 |
ENST00000526145.2
ENST00000531611.1 ENST00000319397.6 ENST00000345075.4 ENST00000535549.1 |
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
| chr20_-_45985464 | 2.36 |
ENST00000458360.2
ENST00000262975.4 |
ZMYND8
|
zinc finger, MYND-type containing 8 |
| chr10_+_24755416 | 2.36 |
ENST00000396446.1
ENST00000396445.1 ENST00000376451.2 |
KIAA1217
|
KIAA1217 |
| chr8_+_123875624 | 2.35 |
ENST00000534247.1
|
ZHX2
|
zinc fingers and homeoboxes 2 |
| chr12_+_56325231 | 2.35 |
ENST00000549368.1
|
DGKA
|
diacylglycerol kinase, alpha 80kDa |
| chr17_+_79027155 | 2.34 |
ENST00000572918.1
|
BAIAP2
|
BAI1-associated protein 2 |
| chr2_+_192543694 | 2.34 |
ENST00000435931.1
|
NABP1
|
nucleic acid binding protein 1 |
| chr10_-_25010795 | 2.32 |
ENST00000416305.1
ENST00000376410.2 |
ARHGAP21
|
Rho GTPase activating protein 21 |
| chr3_-_69402828 | 2.31 |
ENST00000460709.1
|
FRMD4B
|
FERM domain containing 4B |
| chr4_+_169552748 | 2.30 |
ENST00000504519.1
ENST00000512127.1 |
PALLD
|
palladin, cytoskeletal associated protein |
| chr4_-_57547870 | 2.30 |
ENST00000381260.3
ENST00000420433.1 ENST00000554144.1 ENST00000557328.1 |
HOPX
|
HOP homeobox |
| chr3_+_152017924 | 2.27 |
ENST00000465907.2
ENST00000492948.1 ENST00000485509.1 ENST00000464596.1 |
MBNL1
|
muscleblind-like splicing regulator 1 |
| chrX_+_69642881 | 2.26 |
ENST00000453994.2
ENST00000536730.1 ENST00000538649.1 ENST00000374382.3 |
GDPD2
|
glycerophosphodiester phosphodiesterase domain containing 2 |
| chr3_+_184033551 | 2.26 |
ENST00000456033.1
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1 |
| chr3_-_176914238 | 2.25 |
ENST00000430069.1
ENST00000428970.1 |
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1 |
| chr3_-_171177852 | 2.21 |
ENST00000284483.8
ENST00000475336.1 ENST00000357327.5 ENST00000460047.1 ENST00000488470.1 ENST00000470834.1 |
TNIK
|
TRAF2 and NCK interacting kinase |
| chr20_-_45985414 | 2.21 |
ENST00000461685.1
ENST00000372023.3 ENST00000540497.1 ENST00000435836.1 ENST00000471951.2 ENST00000352431.2 ENST00000396281.4 ENST00000355972.4 ENST00000360911.3 |
ZMYND8
|
zinc finger, MYND-type containing 8 |
| chr11_-_122931881 | 2.20 |
ENST00000526110.1
ENST00000227378.3 |
HSPA8
|
heat shock 70kDa protein 8 |
| chr20_-_45985172 | 2.18 |
ENST00000536340.1
|
ZMYND8
|
zinc finger, MYND-type containing 8 |
| chr5_+_36608422 | 2.13 |
ENST00000381918.3
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
| chr1_-_204116078 | 2.09 |
ENST00000367198.2
ENST00000452983.1 |
ETNK2
|
ethanolamine kinase 2 |
| chr2_-_99485825 | 2.08 |
ENST00000423771.1
|
KIAA1211L
|
KIAA1211-like |
| chr5_+_150157860 | 2.07 |
ENST00000600109.1
|
AC010441.1
|
AC010441.1 |
| chr2_-_160761179 | 2.07 |
ENST00000554112.1
ENST00000553424.1 ENST00000263636.4 ENST00000504764.1 ENST00000505052.1 |
LY75
LY75-CD302
|
lymphocyte antigen 75 LY75-CD302 readthrough |
| chr11_+_20044375 | 2.06 |
ENST00000525322.1
ENST00000530408.1 |
NAV2
|
neuron navigator 2 |
| chr14_-_85996332 | 2.03 |
ENST00000380722.1
|
RP11-497E19.1
|
RP11-497E19.1 |
| chr5_-_41794663 | 2.03 |
ENST00000510634.1
|
OXCT1
|
3-oxoacid CoA transferase 1 |
| chr17_+_79031415 | 2.03 |
ENST00000572073.1
ENST00000573677.1 |
BAIAP2
|
BAI1-associated protein 2 |
| chr5_+_150157444 | 2.03 |
ENST00000526627.1
|
SMIM3
|
small integral membrane protein 3 |
| chr10_+_11206925 | 2.01 |
ENST00000354440.2
ENST00000315874.4 ENST00000427450.1 |
CELF2
|
CUGBP, Elav-like family member 2 |
| chr6_-_86353510 | 2.01 |
ENST00000444272.1
|
SYNCRIP
|
synaptotagmin binding, cytoplasmic RNA interacting protein |
| chr5_+_43603229 | 2.01 |
ENST00000344920.4
ENST00000512996.2 |
NNT
|
nicotinamide nucleotide transhydrogenase |
| chr8_-_28243934 | 2.01 |
ENST00000521185.1
ENST00000520290.1 ENST00000344423.5 |
ZNF395
|
zinc finger protein 395 |
| chr4_-_87770416 | 2.00 |
ENST00000273905.6
|
SLC10A6
|
solute carrier family 10 (sodium/bile acid cotransporter), member 6 |
| chr6_+_26158343 | 1.97 |
ENST00000377777.4
ENST00000289316.2 |
HIST1H2BD
|
histone cluster 1, H2bd |
| chr5_+_122847908 | 1.96 |
ENST00000511130.2
ENST00000512718.3 |
CSNK1G3
|
casein kinase 1, gamma 3 |
| chr17_+_7461849 | 1.93 |
ENST00000338784.4
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
| chr9_+_470288 | 1.91 |
ENST00000382303.1
|
KANK1
|
KN motif and ankyrin repeat domains 1 |
| chr11_-_16430399 | 1.90 |
ENST00000528252.1
|
SOX6
|
SRY (sex determining region Y)-box 6 |
| chr1_+_174933899 | 1.90 |
ENST00000367688.3
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
| chr11_-_46639436 | 1.89 |
ENST00000532281.1
|
HARBI1
|
harbinger transposase derived 1 |
| chr11_+_118477144 | 1.89 |
ENST00000361417.2
|
PHLDB1
|
pleckstrin homology-like domain, family B, member 1 |
| chr6_+_21593972 | 1.89 |
ENST00000244745.1
ENST00000543472.1 |
SOX4
|
SRY (sex determining region Y)-box 4 |
| chr5_+_43602750 | 1.88 |
ENST00000505678.2
ENST00000512422.1 ENST00000264663.5 |
NNT
|
nicotinamide nucleotide transhydrogenase |
| chr16_-_19725899 | 1.85 |
ENST00000567367.1
|
KNOP1
|
lysine-rich nucleolar protein 1 |
| chr1_+_33231221 | 1.85 |
ENST00000294521.3
|
KIAA1522
|
KIAA1522 |
| chr2_-_33824336 | 1.85 |
ENST00000431950.1
ENST00000403368.1 ENST00000441530.2 |
FAM98A
|
family with sequence similarity 98, member A |
| chr17_+_7461781 | 1.84 |
ENST00000349228.4
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
| chr3_+_184033135 | 1.84 |
ENST00000424196.1
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1 |
| chr2_+_136289030 | 1.84 |
ENST00000409478.1
ENST00000264160.4 ENST00000329971.3 ENST00000438014.1 |
R3HDM1
|
R3H domain containing 1 |
| chr17_-_74533734 | 1.83 |
ENST00000589342.1
|
CYGB
|
cytoglobin |
| chr10_-_27149851 | 1.81 |
ENST00000376142.2
ENST00000359188.4 ENST00000376139.2 ENST00000376160.1 |
ABI1
|
abl-interactor 1 |
| chr4_-_187517928 | 1.81 |
ENST00000512772.1
|
FAT1
|
FAT atypical cadherin 1 |
| chr5_-_168006324 | 1.80 |
ENST00000522176.1
|
PANK3
|
pantothenate kinase 3 |
| chr14_+_58797974 | 1.80 |
ENST00000417477.2
|
ARID4A
|
AT rich interactive domain 4A (RBP1-like) |
| chr7_-_129592471 | 1.79 |
ENST00000473814.2
ENST00000490974.1 |
UBE2H
|
ubiquitin-conjugating enzyme E2H |
| chr5_-_124082279 | 1.79 |
ENST00000513986.1
|
ZNF608
|
zinc finger protein 608 |
| chr1_+_15986364 | 1.79 |
ENST00000345034.1
|
RSC1A1
|
regulatory solute carrier protein, family 1, member 1 |
| chr2_+_192141611 | 1.78 |
ENST00000392316.1
|
MYO1B
|
myosin IB |
| chr5_-_43313269 | 1.76 |
ENST00000511774.1
|
HMGCS1
|
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
| chr11_+_20044096 | 1.76 |
ENST00000533917.1
|
NAV2
|
neuron navigator 2 |
| chr11_-_59383617 | 1.74 |
ENST00000263847.1
|
OSBP
|
oxysterol binding protein |
| chr10_-_27149904 | 1.74 |
ENST00000376166.1
ENST00000376138.3 ENST00000355394.4 ENST00000346832.5 ENST00000376134.3 ENST00000376137.4 ENST00000536334.1 ENST00000490841.2 |
ABI1
|
abl-interactor 1 |
| chr17_+_7462103 | 1.72 |
ENST00000396545.4
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
| chr16_-_4164027 | 1.71 |
ENST00000572288.1
|
ADCY9
|
adenylate cyclase 9 |
| chr2_-_114300213 | 1.70 |
ENST00000446595.1
ENST00000416105.1 ENST00000450636.1 ENST00000416758.1 |
RP11-395L14.4
|
RP11-395L14.4 |
| chr13_-_20805109 | 1.67 |
ENST00000241124.6
|
GJB6
|
gap junction protein, beta 6, 30kDa |
| chr11_-_118023490 | 1.67 |
ENST00000324727.4
|
SCN4B
|
sodium channel, voltage-gated, type IV, beta subunit |
| chr12_+_19389814 | 1.66 |
ENST00000536974.1
|
PLEKHA5
|
pleckstrin homology domain containing, family A member 5 |
| chr5_+_112074029 | 1.66 |
ENST00000512211.2
|
APC
|
adenomatous polyposis coli |
| chr9_+_109685630 | 1.65 |
ENST00000451160.2
|
RP11-508N12.4
|
Uncharacterized protein |
| chr8_-_116504448 | 1.64 |
ENST00000518018.1
|
TRPS1
|
trichorhinophalangeal syndrome I |
| chr11_-_2170786 | 1.64 |
ENST00000300632.5
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chrX_+_22050546 | 1.63 |
ENST00000379374.4
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked |
| chr12_+_40787194 | 1.63 |
ENST00000425730.2
ENST00000454784.4 |
MUC19
|
mucin 19, oligomeric |
| chr13_-_46742630 | 1.62 |
ENST00000416500.1
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
| chr5_+_50678921 | 1.62 |
ENST00000230658.7
|
ISL1
|
ISL LIM homeobox 1 |
| chr6_-_122792919 | 1.61 |
ENST00000339697.4
|
SERINC1
|
serine incorporator 1 |
| chr7_+_17338239 | 1.60 |
ENST00000242057.4
|
AHR
|
aryl hydrocarbon receptor |
| chr2_-_26467465 | 1.60 |
ENST00000457468.2
|
HADHA
|
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit |
| chr3_+_186501979 | 1.60 |
ENST00000498746.1
|
EIF4A2
|
eukaryotic translation initiation factor 4A2 |
| chr6_-_143266297 | 1.60 |
ENST00000367603.2
|
HIVEP2
|
human immunodeficiency virus type I enhancer binding protein 2 |
| chr16_+_15737124 | 1.60 |
ENST00000396355.1
ENST00000396353.2 |
NDE1
|
nudE neurodevelopment protein 1 |
| chr7_-_83824169 | 1.59 |
ENST00000265362.4
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
| chr12_+_101188718 | 1.57 |
ENST00000299222.9
ENST00000392977.3 |
ANO4
|
anoctamin 4 |
| chr11_+_118230287 | 1.57 |
ENST00000252108.3
ENST00000431736.2 |
UBE4A
|
ubiquitination factor E4A |
| chr4_+_144354644 | 1.56 |
ENST00000512843.1
|
GAB1
|
GRB2-associated binding protein 1 |
| chr4_+_169633310 | 1.56 |
ENST00000510998.1
|
PALLD
|
palladin, cytoskeletal associated protein |
| chr11_-_61348292 | 1.55 |
ENST00000539008.1
ENST00000540677.1 ENST00000542836.1 ENST00000542670.1 ENST00000535826.1 ENST00000545053.1 |
SYT7
|
synaptotagmin VII |
| chr17_-_62308087 | 1.55 |
ENST00000583097.1
|
TEX2
|
testis expressed 2 |
| chr5_-_41794313 | 1.53 |
ENST00000512084.1
|
OXCT1
|
3-oxoacid CoA transferase 1 |
| chrX_+_64808248 | 1.51 |
ENST00000609672.1
|
MSN
|
moesin |
| chr4_+_3076388 | 1.48 |
ENST00000355072.5
|
HTT
|
huntingtin |
| chr14_-_50319758 | 1.45 |
ENST00000298310.5
|
NEMF
|
nuclear export mediator factor |
Network of associatons between targets according to the STRING database.
First level regulatory network of NFIA
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.1 | 18.3 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
| 4.0 | 12.0 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 2.7 | 8.0 | GO:1902362 | melanocyte apoptotic process(GO:1902362) |
| 1.8 | 5.3 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 1.8 | 8.8 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 1.4 | 5.6 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 1.2 | 3.6 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 1.1 | 8.0 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 1.1 | 6.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.1 | 20.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 1.0 | 4.0 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 1.0 | 12.0 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 1.0 | 2.9 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 1.0 | 5.9 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.9 | 3.4 | GO:0072086 | specification of loop of Henle identity(GO:0072086) pattern specification involved in metanephros development(GO:0072268) |
| 0.8 | 2.5 | GO:1903515 | calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 0.8 | 28.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.8 | 6.8 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.7 | 6.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
| 0.7 | 1.5 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.7 | 15.4 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.7 | 2.8 | GO:0048936 | visceral motor neuron differentiation(GO:0021524) peripheral nervous system neuron axonogenesis(GO:0048936) cardiac cell fate determination(GO:0060913) positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
| 0.7 | 3.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.7 | 4.6 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.6 | 1.9 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.6 | 3.1 | GO:1904764 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.6 | 5.2 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.6 | 3.9 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.5 | 9.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.5 | 8.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.5 | 2.4 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.5 | 4.4 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 0.5 | 3.8 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.5 | 3.3 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.5 | 1.9 | GO:0035905 | N-terminal peptidyl-lysine acetylation(GO:0018076) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.5 | 6.9 | GO:0060613 | fat pad development(GO:0060613) |
| 0.5 | 0.9 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.4 | 3.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.4 | 14.0 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.4 | 6.6 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.4 | 0.9 | GO:0042704 | uterine wall breakdown(GO:0042704) |
| 0.4 | 4.9 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.4 | 21.7 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.4 | 2.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.4 | 1.6 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
| 0.4 | 1.6 | GO:1990927 | short-term synaptic potentiation(GO:1990926) calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.4 | 1.5 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.4 | 2.6 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.4 | 1.1 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.3 | 3.8 | GO:0070779 | gamma-aminobutyric acid biosynthetic process(GO:0009449) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.3 | 1.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.3 | 2.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.3 | 2.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.3 | 2.6 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.3 | 1.0 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.3 | 3.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.3 | 4.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.3 | 1.8 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.3 | 2.4 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.3 | 2.4 | GO:0030578 | PML body organization(GO:0030578) |
| 0.3 | 3.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.3 | 0.8 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.3 | 1.6 | GO:1904383 | response to sodium phosphate(GO:1904383) |
| 0.3 | 0.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.3 | 3.2 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.3 | 1.6 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.3 | 6.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.3 | 1.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.2 | 5.2 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.2 | 1.4 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.2 | 2.4 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 | 2.3 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.2 | 0.9 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.2 | 2.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.2 | 2.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.2 | 5.5 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.2 | 1.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
| 0.2 | 1.4 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.2 | 9.5 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.2 | 4.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.2 | 5.2 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.2 | 1.1 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.2 | 0.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.2 | 0.7 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 0.2 | 1.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.2 | 2.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 | 1.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.2 | 0.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.2 | 0.7 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.2 | 4.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.2 | 0.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.2 | 3.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.2 | 4.4 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.2 | 8.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.2 | 0.8 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 | 1.6 | GO:2000467 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.1 | 1.3 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.1 | 1.1 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.1 | 3.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.1 | 0.5 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) regulation of cellular response to insulin stimulus(GO:1900076) |
| 0.1 | 0.7 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 | 3.4 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 0.3 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.1 | 1.0 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 | 1.9 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 | 1.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 1.0 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
| 0.1 | 1.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 0.8 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 | 1.7 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) |
| 0.1 | 2.9 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.1 | 1.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 0.1 | 1.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.1 | 3.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.1 | 3.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 | 2.5 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.1 | 1.1 | GO:0021603 | cranial nerve formation(GO:0021603) |
| 0.1 | 1.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 6.0 | GO:0097435 | fibril organization(GO:0097435) |
| 0.1 | 2.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 1.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 | 0.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.1 | 3.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.1 | 1.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.1 | 1.9 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 | 0.6 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.1 | 0.9 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 | 1.5 | GO:0051168 | nuclear export(GO:0051168) |
| 0.1 | 4.9 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
| 0.1 | 19.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 | 0.5 | GO:0001555 | oocyte growth(GO:0001555) |
| 0.1 | 9.6 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.1 | 0.2 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.1 | 22.9 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
| 0.1 | 1.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
| 0.1 | 2.9 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.1 | 0.5 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.1 | 1.3 | GO:0072189 | ureter development(GO:0072189) |
| 0.1 | 1.4 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.1 | 3.7 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.1 | 0.8 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 | 0.6 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
| 0.1 | 4.8 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
| 0.1 | 0.8 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.1 | 1.2 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 0.1 | 0.4 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.1 | 0.3 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
| 0.1 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.1 | 1.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.1 | 1.4 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.1 | 1.0 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 12.5 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
| 0.1 | 0.4 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.1 | 0.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 | 0.6 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.0 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.0 | 0.6 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
| 0.0 | 1.8 | GO:0050796 | regulation of insulin secretion(GO:0050796) |
| 0.0 | 1.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.0 | 9.9 | GO:0016573 | histone acetylation(GO:0016573) |
| 0.0 | 0.1 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.0 | 1.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 2.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.0 | 0.3 | GO:0055065 | metal ion homeostasis(GO:0055065) |
| 0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 | 0.8 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.0 | 0.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.0 | 0.9 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
| 0.0 | 0.3 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.0 | 0.9 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.0 | 1.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.0 | 0.1 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.0 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
| 0.0 | 0.8 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.0 | 1.2 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
| 0.0 | 1.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.0 | 0.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.0 | 0.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.0 | 1.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.0 | 1.2 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.0 | 2.3 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 | 0.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 | 0.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.0 | 1.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 0.0 | 0.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
| 0.0 | 3.3 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.0 | 0.3 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.0 | 3.7 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.0 | 1.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 2.0 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.0 | 1.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.7 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
| 0.0 | 3.1 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
| 0.0 | 0.8 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
| 0.0 | 0.4 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.0 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.0 | 0.7 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
| 0.0 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.0 | 0.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.0 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 | 1.0 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
| 0.0 | 0.4 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.0 | 1.6 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 | 0.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.0 | 0.4 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
| 0.0 | 0.3 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.0 | 1.3 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.0 | 0.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.0 | 2.4 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
| 0.0 | 0.3 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.0 | 2.6 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.0 | 0.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 | 3.3 | GO:0008360 | regulation of cell shape(GO:0008360) |
| 0.0 | 0.7 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.0 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 | 0.3 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.0 | 1.0 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.0 | 0.2 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 | 0.4 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
| 0.0 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.0 | 12.0 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 1.4 | 8.1 | GO:0031673 | H zone(GO:0031673) |
| 0.9 | 6.9 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.5 | 46.7 | GO:0045095 | keratin filament(GO:0045095) |
| 0.4 | 8.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.4 | 3.1 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.4 | 4.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.4 | 1.5 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
| 0.3 | 1.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.3 | 24.8 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.3 | 1.6 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.3 | 1.2 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.3 | 1.2 | GO:0070939 | Dsl1p complex(GO:0070939) RZZ complex(GO:1990423) |
| 0.3 | 2.3 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.3 | 1.1 | GO:0043293 | apoptosome(GO:0043293) |
| 0.3 | 2.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.3 | 4.9 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.3 | 3.2 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.3 | 1.0 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.3 | 2.0 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.2 | 4.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.2 | 1.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.2 | 5.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.2 | 1.3 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.2 | 2.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.2 | 5.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.2 | 0.6 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.2 | 2.5 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.2 | 1.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.2 | 3.1 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 1.6 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.1 | 13.3 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 1.6 | GO:0032009 | early phagosome(GO:0032009) |
| 0.1 | 2.0 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 1.2 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.1 | 1.3 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 1.0 | GO:0070695 | FHF complex(GO:0070695) |
| 0.1 | 10.4 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 0.4 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.1 | 6.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 9.4 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 19.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 2.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 1.9 | GO:0045180 | basal cortex(GO:0045180) |
| 0.1 | 16.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 9.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.1 | 1.5 | GO:0071437 | invadopodium(GO:0071437) |
| 0.1 | 3.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 2.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 2.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.1 | 2.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.1 | 1.7 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 1.1 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 5.1 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 0.6 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 5.1 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 0.3 | GO:0044308 | axonal spine(GO:0044308) |
| 0.0 | 0.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.0 | 0.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 0.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.0 | 0.8 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.0 | 4.6 | GO:0036477 | somatodendritic compartment(GO:0036477) |
| 0.0 | 1.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.0 | 0.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.0 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
| 0.0 | 0.3 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.0 | 0.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.0 | 0.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 0.4 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.0 | 0.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.0 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.0 | 1.1 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 0.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.0 | 2.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.0 | 4.1 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 6.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 1.0 | GO:0030424 | axon(GO:0030424) |
| 0.0 | 2.0 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 1.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 2.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 1.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.0 | 3.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.0 | 1.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 3.1 | GO:0005884 | actin filament(GO:0005884) |
| 0.0 | 0.6 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.0 | 1.6 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 1.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.0 | 1.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.0 | 0.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.0 | 0.8 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 2.3 | GO:0043679 | axon terminus(GO:0043679) |
| 0.0 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.0 | 3.3 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 1.0 | GO:0000786 | nucleosome(GO:0000786) |
| 0.0 | 1.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 2.1 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 1.6 | GO:0016234 | inclusion body(GO:0016234) |
| 0.0 | 2.8 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 3.3 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 1.9 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 12.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 1.9 | 5.7 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 1.3 | 3.9 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 1.1 | 4.6 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.9 | 3.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 0.9 | 2.6 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 0.8 | 2.5 | GO:0031775 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
| 0.8 | 18.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.8 | 4.9 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.7 | 2.2 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.6 | 5.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.6 | 8.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.5 | 2.9 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.5 | 2.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.4 | 1.6 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.4 | 1.2 | GO:0019961 | interferon binding(GO:0019961) |
| 0.4 | 2.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.4 | 3.8 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.4 | 1.9 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.4 | 4.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.3 | 1.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.3 | 2.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.3 | 2.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.3 | 47.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.3 | 14.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.3 | 5.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.3 | 6.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.3 | 11.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.3 | 3.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.3 | 2.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.3 | 3.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.3 | 3.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.3 | 1.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.3 | 2.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.3 | 7.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.2 | 0.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.2 | 9.0 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.2 | 1.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.2 | 2.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.2 | 6.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.2 | 0.7 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.2 | 8.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.2 | 24.9 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.2 | 10.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.2 | 1.9 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.2 | 0.9 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.2 | 1.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.2 | 0.8 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.2 | 1.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.2 | 4.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.2 | 4.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.2 | 2.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.2 | 4.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.2 | 1.7 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.2 | 0.8 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.1 | 3.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.1 | 0.6 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.1 | 1.3 | GO:0032450 | alpha-1,4-glucosidase activity(GO:0004558) maltose alpha-glucosidase activity(GO:0032450) |
| 0.1 | 3.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 6.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.1 | 3.9 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.1 | 3.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.1 | 0.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 0.4 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
| 0.1 | 0.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 5.4 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.1 | 6.3 | GO:0043236 | laminin binding(GO:0043236) |
| 0.1 | 3.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 2.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.1 | 2.7 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.1 | 1.1 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.1 | 0.9 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.1 | 0.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.1 | 0.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.1 | 3.2 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.1 | 1.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.1 | 1.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.1 | 1.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 0.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.1 | 1.5 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.1 | 1.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 5.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.1 | 3.0 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 2.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.1 | 1.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.1 | 1.1 | GO:0008526 | phosphatidylcholine transporter activity(GO:0008525) phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 1.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 0.7 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.1 | 0.3 | GO:0031751 | D2 dopamine receptor binding(GO:0031749) D4 dopamine receptor binding(GO:0031751) |
| 0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.1 | 2.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 12.1 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.1 | 10.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 0.8 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 0.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.1 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.1 | 0.2 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 0.2 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.1 | 1.1 | GO:0070513 | death domain binding(GO:0070513) |
| 0.1 | 3.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.1 | 1.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.1 | 4.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.1 | 0.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.1 | 1.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 0.9 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
| 0.1 | 1.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 2.0 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.1 | 0.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.1 | 1.0 | GO:0030674 | protein binding, bridging(GO:0030674) binding, bridging(GO:0060090) |
| 0.1 | 1.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 8.1 | GO:0002020 | protease binding(GO:0002020) |
| 0.0 | 2.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.0 | 1.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.0 | 2.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 0.1 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
| 0.0 | 1.8 | GO:0008200 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
| 0.0 | 2.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.0 | 1.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 1.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.0 | 2.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.8 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.0 | 1.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.0 | 3.7 | GO:0044212 | regulatory region DNA binding(GO:0000975) transcription regulatory region DNA binding(GO:0044212) |
| 0.0 | 1.2 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.0 | 0.3 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.0 | 1.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.0 | 1.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 2.0 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.0 | 31.8 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 0.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.0 | 0.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 5.2 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 1.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.0 | 0.1 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.0 | 0.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 0.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.0 | 0.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 0.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.0 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.0 | 2.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.0 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 1.1 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.0 | 14.0 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.0 | 0.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.0 | 3.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 1.3 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.0 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.0 | 0.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.0 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.0 | 1.3 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.0 | 0.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.0 | 0.9 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.0 | 0.1 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.0 | 0.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 0.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.0 | 1.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.0 | 0.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 2.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 11.3 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 2.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 39.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.3 | 16.7 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.2 | 10.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.2 | 7.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.2 | 15.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.2 | 16.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.2 | 4.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.1 | 10.3 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 35.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 8.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 9.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 1.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.1 | 4.0 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.1 | 5.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.0 | 6.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 0.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.0 | 1.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.0 | 1.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 1.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 14.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 1.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.0 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 4.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 4.8 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 0.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 2.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 2.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 0.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 0.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.0 | 1.5 | PID P73PATHWAY | p73 transcription factor network |
| 0.0 | 1.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.0 | 0.9 | PID ATR PATHWAY | ATR signaling pathway |
| 0.0 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.0 | 0.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 0.8 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.0 | 0.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.0 | 0.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 10.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.4 | 8.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.4 | 4.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.3 | 5.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.3 | 6.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.2 | 10.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.2 | 5.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.2 | 6.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.1 | 5.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 2.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.1 | 3.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 3.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.1 | 4.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.1 | 3.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.1 | 2.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 2.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 2.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 1.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 2.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 2.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 4.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 13.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.1 | 1.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 7.9 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.1 | 4.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 1.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 3.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 2.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 3.6 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
| 0.1 | 1.6 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
| 0.1 | 4.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.1 | 1.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 1.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.1 | 1.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 6.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.1 | 10.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 1.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.1 | 8.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.0 | 3.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 1.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.0 | 3.7 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.0 | 1.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.0 | 2.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.0 | 0.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.0 | 0.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.0 | 1.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.0 | 0.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 0.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 0.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 0.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
| 0.0 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.0 | 0.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |